31 October 2018 in PLOS ONE
DNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regions that are differentially methylated in T cells of patients with relapsing remitting multiple sclerosis (MS) compared to healthy controls. DNA methylation was assessed at 450,000 genomic sites in CD4+ and CD8+ T cells purified from peripheral blood of 94 women with MS and 94 healthy women, and differentially methylated regions were identified using bumphunter. Differential DNA methylation was observed near four loci: MOG/ZFP57, HLA-DRB1, NINJ2/LOC100049716, and SLFN12. Increased methylation of the first exon of the SLFN12 gene was observed in both T cell subtypes and remained present after restricting analyses to samples from patients who had never been on treatment or had been off treatment for more than 2.5 years. Genes near the regions of differential methylation in T cells were assessed for differential expression in whole blood samples from a separate population of 1,329 women with MS and 97 healthy women. Gene expression of HLA-DRB1, NINJ2, and SLFN12 was observed to be decreased in whole blood in MS patients compared to controls. We conclude that T cells from MS patients display regions of differential DNA methylation compared to controls, and corresponding gene expression differences are observed in whole blood. Two of the genes that showed both methylation and expression differences, NINJ2 and SLFN12, have not previously been implicated in MS. SLFN12 is a particularly compelling target of further research, as this gene is known to be down-regulated during T cell activation and up-regulated by type I interferons (IFNs), which are used to treat MS.
31 October 2023 in npj Parkinson's Disease
Understanding the contribution of immune mechanisms to Parkinson’s disease pathogenesis is an important challenge, potentially of major therapeutic implications. To further elucidate the involvement of peripheral immune cells, we studied epigenome-wide DNA methylation in isolated populations of CD14+ monocytes, CD19+ B cells, CD4+ T cells, and CD8+ T cells from Parkinson’s disease patients and healthy control participants. We included 25 patients with a maximum five years of disease duration and 25 controls, and isolated four immune cell populations from each fresh blood sample. Epigenome-wide DNA methylation profiles were generated from 186 samples using the Illumina MethylationEpic array and association with disease status was tested using linear regression models. We identified six differentially methylated CpGs in CD14+ monocytes and one in CD8 + T cells. Four differentially methylated regions were identified in monocytes, including a region upstream of RAB32, a gene that has been linked to LRRK2. Methylation upstream of RAB32 correlated negatively with mRNA expression, and RAB32 expression was upregulated in Parkinson’s disease both in our samples and in summary statistics from a previous study. Our epigenome-wide association study of early Parkinson’s disease provides evidence for methylation changes across different peripheral immune cell types, highlighting monocytes and the RAB32 locus. The findings were predominantly cell-type-specific, demonstrating the value of isolating purified cell populations for genomic studies.
6 October 2026 in PLOS Computational Biology
Transcription is regulated through the sequence-specific binding of transcription factors (TFs) to cis-regulatory regions (CRRs); DNA variants in CRRs can disrupt TF-DNA interactions and gene regulatory networks through a cascading effect. Despite a few cases of reported recurrent cis-regulatory variants (CRVs), another approach for detecting non-coding functional events relies on combining gene-CRR associations capturing the regulatory elements controlling gene transcription, and functional impact (FI) scores quantifying the deleterious effect of variants. While many methods exist for each, how much they agree and how strongly the choice of CRR-FI score combination impacts the prediction of cis-regulatory altered genes has not been systematically assessed. Here, we demonstrate that gene-CRR associations and FI scoring methods exhibit little consensus, highlighting the impact of the choice of a specific CRR-FI score combination in a given analysis. These observations point to the need for a systematic approach to evaluate several gene-CRR and FI scoring methods in a unified framework. To address this gap, we developed HiFIseek, a Snakemake pipeline of two enrichment detection methods exploring the enrichment of high FI variants in CRRs associated with a gene using all region-score combinations. We applied HiFIseek to detect genes exhibiting high functional impact CRVs in eight cancer cohorts and a set of breast cancer risk-associated single-nucleotide polymorphisms (SNPs). We demonstrate that cancer driver genes exhibit a higher frequency of FI CRVs compared to non-cancer genes. In the cancer cohorts, HiFIseek detected genes pointing to cancer-related pathways with enrichment for high FI CRVs despite a small degree of agreement across CRR-FI score combinations. In the SNP cohort, HiFIseek found again small consensus across CRR-score combinations, one of which returned 18 known cancer-related genes, including BRCA1 , showing an enrichment of high-impact CRVs.